ddd107498 and Malaria--Falciparum

ddd107498 has been researched along with Malaria--Falciparum* in 1 studies

Other Studies

1 other study(ies) available for ddd107498 and Malaria--Falciparum

ArticleYear
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Antimalarial drug resistance in the

    Topics: Animals; Antimalarials; Drug Resistance; Drug Therapy, Combination; Hemeproteins; Malaria, Falciparum; Mice; Mice, SCID; Naphthyridines; Peptide Elongation Factor 2; Plasmodium falciparum; Quinolines

2020